BioSpace News Archive

Business

Zealand Abandons Sanofi Diabetes Drug in $205 Million Deal with Royalty Pharma

Copenhagen-based Zealand Pharma is selling future royalty streams and $85 million in potential commercial milestones for two diabetes drugs, Soliqua/Suliqua and Lyxumia/Adlyxin, to New York-based Royalty Pharma.

September 7, 2018
·
3 min read
·
Mark Terry
We Want to Hear from You! Top Life Sciences Trends

As a valued member of our BioSpace community, we are eager to hear more from you and other readers.

September 7, 2018
·
1 min read
·
Editorial Staff
6 Important Reasons You Should Always Take Your Paid Vacation Time

Neglecting vacation time can have serious consequences, not only to your own personal health and happiness levels, but also a large-scale financial and economic impact.

September 7, 2018
·
3 min read
·
Editorial Staff
Business

BioSpace Online Community Shares Job Openings With Industry Colleagues Who Lost Jobs

Job hunting can be a challenging time for people. Finding open positions that fit your skill set and then competing with other highly-qualified people can be bruising, especially if you’re already a bit damaged from a recent layoff.

September 7, 2018
·
3 min read
·
Alex Keown